Management of Atrial Fibrillation with Bradycardia

Immediate Assessment and Critical Decision Point

• The American College of Cardiology recommends stopping all rate-controlling medications immediately and assessing for hemodynamic instability in patients with atrial fibrillation and bradycardia, with symptoms such as hypotension, altered mental status, heart failure, or angina, and proceeding directly to temporary pacing followed by permanent pacemaker implantation if necessary 1, 2.
• The American College of Cardiology suggests assessing hemodynamic status immediately, including blood pressure, mental status, signs of heart failure, chest pain, and end-organ perfusion, in patients with atrial fibrillation and bradycardia 1, 2.
• The European Heart Journal recommends determining if bradycardia is symptomatic, with symptoms such as dizziness, syncope, presyncope, fatigue, dyspnea, or chest pain, indicating the need for urgent intervention 7.

Management Algorithm

For Symptomatic Bradycardia

• The American College of Cardiology recommends initiating temporary transcutaneous or transvenous pacing immediately in patients with symptomatic bradycardia and hemodynamic compromise 1, 2.
• The American College of Cardiology suggests discontinuing all AV nodal blocking agents, such as beta-blockers, calcium channel blockers, and digoxin, in patients with symptomatic bradycardia 1, 2, 5.
• The European Heart Journal recommends considering atropine 0.5-1 mg IV as a temporizing measure while arranging pacing in patients with symptomatic bradycardia, although its efficacy in atrial fibrillation is limited 7.

Special Consideration: Catheter Ablation Strategy

• The European Society of Cardiology recommends catheter ablation for patients with atrial fibrillation-related bradycardia or sinus pauses occurring when atrial fibrillation terminates, as it addresses the underlying arrhythmia substrate rather than requiring permanent pacing 7.

Anticoagulation Management During Bradycardia

• The American College of Cardiology recommends continuing anticoagulation regardless of heart rate in patients with atrial fibrillation, as stroke risk persists independent of ventricular rate 1, 6.
• The European Heart Journal suggests assessing stroke risk using the CHA₂DS₂-VASc score and initiating or continuing oral anticoagulation for a score of 2 or higher, preferring direct oral anticoagulants over warfarin 6, 7.

Long-Term Management Strategy

If Pacemaker is Required

• The American College of Cardiology recommends implanting a permanent pacemaker first, then resuming rate-controlling medications as needed for atrial fibrillation management 1, 2.
• The European Heart Journal suggests considering AV node ablation with cardiac resynchronization therapy in severely symptomatic patients with permanent atrial fibrillation and heart failure to reduce symptoms, hospitalizations, and mortality 7.

If Pacemaker is Not Required

• The American College of Cardiology recommends restarting rate-controlling medications cautiously at lower doses once heart rate recovers, targeting 60-80 bpm at rest 1, 5.
• The American College of Cardiology suggests avoiding digoxin as the sole agent for rate control, particularly in paroxysmal atrial fibrillation, and monitoring exercise heart rate as rate control at rest does not guarantee adequate control during activity 1, 2, 5, 8.